IMMX: BofA Initiates Buy
B of A Securities initiates coverage on Immix Biopharma with a buy rating and a price target of $27
B of A Securities initiates coverage on Immix Biopharma with a buy rating and a price target of $27
B of A Securities initiates coverage on Immix Biopharma with a buy rating and a price target of $27
B of A Securities initiates coverage on Immix Biopharma with a buy rating and a price target of $27